P2F (Phama to Food) Ventures Limited was set up in 2012 by Steve Morrison, formerly the Chief Operating Officer of Provexis plc.  In 2009 Provexis plc became the first European company to achieve an Article 13.5 health claim, under EC Regulation 1924/2006, for a water soluble tomato concentrate that “helps maintain normal platelet aggregation which contributes to healthy blood flow”1.

Prior to working in the functional food sector Steve Morrison had spent > 20 years in the pharmaceutical industry, in drug development,  working for small, medium and large pharmaceutical companies and encompassing roles as a Director R&D Project Management,  International Project Leader and  Clinical Research Associate.   Dealing with the regulators and developing a strong understanding of the principles of Good Clinical Practice (GCP).

Since incorporation P2F Ventures limited has worked with clients in Norway, Netherlands, Germany, Denmark, France and UK.

1 http://www.efsa.europa.eu/en/efsajournal/pub/1689   The EFSA Journal (2009) 1101, 1-15